Back to Authors

Geda, Yonas E.

https://orcid.org/0000-0003-1187-7230

A5058106909 | I1324766304

Mayo Clinic

for the DIAGNOSE CTE Research Project

Citations 226

Apathy associated with neurocognitive disorders: Recent progress and future directions

Alzheimer's & Dementia | June 28, 2016 | Volume: 13 | Issue: 1 | Pages: 84-100

10.1016/j.jalz.2016.05.008 | PMID 27362291

Abstract Introduction Apathy is common in neurocognitive disorders (NCDs) such as Alzheimer's disease and mild cognitive impairment. Although the definition of apathy is inconsistent in the literature, apathy is primarily defined as a loss of motivation and decreased interest in daily activities. Methods The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Neuropsychiatric Syndromes Professional Interest Area (NPS‐PIA) Apathy workgroup reviewed the latest research regarding apathy in NCDs. Results Progress has recently been made in three areas relevant to apathy: (1) phenomenology, including the use of diagnostic criteria and novel instruments for measurement, (2) neurobiology, including neuroimaging, neuropathological and biomarker correlates, and (3) interventions, including pharmacologic, nonpharmacologic, and noninvasive neuromodulatory approaches. Discussion Recent progress confirms that apathy has a significant impact on those with major NCD and those with mild NCDs. As such, it is an important target for research and intervention.
Multimorbidity and neuroimaging biomarkers among cognitively normal persons

Neurology | April 14, 2016 | Volume: 86 | Issue: 22 | Pages: 2077-2084

10.1212/wnl.0000000000002624 | PMID 27164657

Effect of intellectual enrichment on AD biomarker trajectories

Neurology | February 25, 2016 | Volume: 86 | Issue: 12 | Pages: 1128-1135

10.1212/wnl.0000000000002490 | PMID 26911640

Decline in Weight and Incident Mild Cognitive Impairment

JAMA Neurology | February 1, 2016 | Volume: 73 | Issue: 4 | Pages: 439

10.1001/jamaneurol.2015.4756 | PMID 26831542

Frailty and Mortality Outcomes in Cognitively Normal Older People: Sex Differences in a Population‐Based Study

Journal of the American Geriatrics Society | January 19, 2016 | Volume: 64 | Issue: 1 | Pages: 132-137

10.1111/jgs.13821 | PMID 26782862

Objectives To characterize frailty in cognitively normal older adults at baseline and to investigate the relationship between frailty and mortality. Design Population‐based prospective cohort study: Mayo Clinic Study of Aging. Setting Olmsted County, Minnesota. Participants Cognitively normal older persons aged 70 and older (mean age 78.8 ± 5.2, 50.2% male; N = 2,356). Measurements Frailty was assessed at baseline using a 36‐item Frailty Index. Four frailty subgroups were identified based on the Frailty Index (≤0.10 (fit), 0.11–0.20 (at risk), 0.21–0.30 (frail), >0.30 (frailest)). All participants underwent comprehensive clinical and cognitive assessments. The association between frailty and mortality was assessed using Cox proportional hazards models. Results The median Frailty Index was 0.17 (interquartile range 0.11–0.22). Frailty increased with age and was more common in older men than in older women. Over a median follow‐up of 6.5 years (range 7 days to 8.9 years), 500 of the 2,356 participants died, including 292 men. The frailest participants had the greatest risk of death (hazard ratio ( HR ) = 3.91, 95% confidence interval ( CI ) = 2.69–5.68). The association was stronger in women ( HR = 5.26, 95% CI = 2.88–9.61) than men ( HR = 3.15, 95% CI = 1.98–5.02). Conclusion Baseline frailty was common, especially in older men, and increased with age. Frailty was associated with significantly greater risk of death, particularly in women. These sex differences should be considered when designing a geriatric care plan.
P2‐081: Novel antibody‐based strategies to investigate biomarkers of Alzheimerˈs disease

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2015.06.618

F5‐05‐03: Nps in normal cognition and the risk of developing MCI and dementia in the presence of late‐onset nps

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_6 | Pages: No page available

10.1016/j.jalz.2015.07.441

F5‐01‐03: Better intellectual lifestyle to keep cognitive impairment away

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_6 | Pages: No page available

10.1016/j.jalz.2015.07.425

O3‐11‐06: Caloric intake and the risk of mild cognitive impairment: A population‐based cohort study

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_5 | Pages: No page available

10.1016/j.jalz.2015.07.302

P4‐013: Perturbation of 3R/4R tau ratio impairs app axonal transport in neurons derived from human embryonic stem cells (HESC)

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_16 | Pages: No page available

10.1016/j.jalz.2015.06.1717